1.280USD-0.78%Mkt Cap: 88.72M USDP/E: —Last update: 2026-05-26
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap88.72M USD
Enterprise Value84.05M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.41M USD
Revenue/Share—
Last Price1.280 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.64
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B7.56
EPS (TTM)-0.29
EPS (Forward)-0.28
52W Range
1.05011% of range3.100
52W High3.100 USD
52W Low1.050 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-176.10%
ROA-141.84%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.69M USD
CapEx (TTM)—
FCF Margin—
FCF Yield0.21%
Net Debt-5.36M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity4.09
Current Ratio7.00
Quick Ratio6.72
Book Value/Sh0.1720 USD
Cash/Share0.0810 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.68.77M
Float38.06M
Insiders35.10%
Institutions3.26%
Short Interest
Short Ratio4.8d
Short % Float1.85%
Short % Out.1.49%
Shares Short1.02M
Short (prev mo.)1.23M
Technical
SMA 501.320 (-3.0%)
SMA 2001.369 (-6.5%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)192.49K
Avg Vol (10d)90.58K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—